On 2025-05-15, Mersana Therapeutics, Inc. (MRSN) announced earnings per share of $-0.19 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.21.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.15 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.21 | $-0.19 |
| 2025-03-03 | 2024-12-31 | $-0.16 | $-0.11 |
| 2024-11-13 | 2024-09-30 | $-0.18 | $-0.09 |
| 2024-08-13 | 2024-06-30 | $-0.18 | $-0.20 |
| 2024-05-09 | 2024-03-31 | $-0.18 | $-0.16 |
| 2024-02-28 | 2023-12-31 | $-0.20 | $-0.16 |
| 2023-11-07 | 2023-09-30 | $-0.31 | $-0.35 |
| 2023-08-08 | 2023-06-30 | $-0.39 | $-0.47 |
| 2023-05-09 | 2023-03-31 | $-0.41 | $-0.52 |
| 2023-02-28 | 2022-12-31 | $-0.47 | $-0.44 |
| 2022-11-07 | 2022-09-30 | $-0.03 | $-0.61 |
| 2022-08-08 | 2022-06-30 | $-0.50 | $-0.55 |
| 2022-05-09 | 2022-03-31 | $-0.31 | $-0.59 |
| 2022-02-28 | 2021-12-31 | $-0.67 | $-0.68 |
| 2021-11-09 | 2021-09-30 | $-0.58 | $-0.63 |
| 2021-08-06 | 2021-06-30 | $-0.50 | $-0.59 |
| 2021-05-10 | 2021-03-31 | $-0.39 | $-0.50 |
| 2021-02-26 | 2020-12-31 | $-0.33 | $-0.42 |
| 2020-11-09 | 2020-09-30 | $-0.31 | $-0.33 |
| 2020-08-07 | 2020-06-30 | $-0.30 | $-0.33 |
| 2020-05-08 | 2020-03-31 | $-0.38 | $-0.35 |
| 2020-02-28 | 2019-12-31 | $-0.38 | $-0.34 |
| 2019-11-06 | 2019-09-30 | $-0.37 | $-0.35 |
| 2019-08-08 | 2019-06-30 | $-0.38 | $-0.36 |
| 2019-05-09 | 2019-03-31 | $-0.03 | $0.70 |
| 2019-03-08 | 2018-12-31 | $-0.69 | $-0.97 |
| 2018-11-13 | 2018-09-30 | $-0.59 | $-0.75 |
| 2018-08-14 | 2018-06-30 | $-0.58 | $-0.54 |
| 2018-05-14 | 2018-03-31 | $-0.61 | $-0.54 |
| 2018-03-28 | 2017-12-31 | $-0.48 | $-0.61 |
| 2017-11-09 | 2017-09-30 | $-0.45 | $-0.35 |
| 2017-08-11 | 2017-06-30 | $-0.56 | $-6.33 |